BEOVU Versus Eylea in the Treatment of Age-related Macular Neovascular Degeneration

• Status: Recruiting
• Trial end date: 2022-03-01
• Target enrollment: 0
• Participant gender: All

Summary

Age-Related macular neovascularization degeneration occur is a vision threatening condition. The investigators compare the efficacy of BEOVU and Eylea intravitreal treatment in the management.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Benha University

Criteria

Inclusion Criteria:

• • Age-Related macular neovascularization degeneration

Exclusion Criteria:

• other causes of macular neovascularization degeneration

• other macular diseases